Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Epstein

Showing results (601-610 of 635) with videos related to

Pageof 64
Sort By:
The American Journal of Surgical Pathology|August 19, 2008
Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimensAndrew J Evans, Pauline C Henry, Theodorus H Van der Kwast, et al.
Virchows Archiv : an International Journal of Pathology|October 16, 2014
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologistRodolfo Montironi, Elizabeth H Hammond, Daniel W Lin, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome AnalysisBurles A Johnson Iii, Benjamin A Teply, Catherine Kagemann, et al.
The American Journal of Surgical Pathology|October 23, 2013
Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a): an interobserver study among genitourinary pathologistsVijayalakshmi Ananthanarayanan, Yi Pan, Maria Tretiakova, et al.
The American Journal of Surgical Pathology|July 28, 2022
Clinicopathologic Spectrum of Secondary Solid Tumors of the Prostate of Nonurothelial Origin: Multi-institutional Evaluation of 85 CasesAndres M Acosta, Jennifer B Gordetsky, Katrina Collins, et al.
Archives of Pathology & Laboratory Medicine|August 6, 2014
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer FoundationMahul B Amin, Daniel W Lin, John L Gore, et al.
The American Journal of Pathology|September 6, 2011
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypesChristopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, et al.
The American Journal of Pathology|February 13, 2002
Evaluation of non-formalin tissue fixation for molecular profiling studiesJohn W Gillespie, Carolyn J M Best, Verena E Bichsel, et al.
The American Journal of Surgical Pathology|October 5, 2018
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the KidneyLisha Wang, Yuping Zhang, Ying-Bei Chen, et al.
The Journal of Pathology|October 18, 2023
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancerRadhika A Patel, Erolcan Sayar, Ilsa Coleman, et al.
Pageof 64

Showing results (601-610 of 635) with videos related to

Sort By:
Pageof 64
The American Journal of Surgical Pathology|August 19, 2008
Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimensAndrew J Evans, Pauline C Henry, Theodorus H Van der Kwast, et al.
Virchows Archiv : an International Journal of Pathology|October 16, 2014
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologistRodolfo Montironi, Elizabeth H Hammond, Daniel W Lin, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome AnalysisBurles A Johnson Iii, Benjamin A Teply, Catherine Kagemann, et al.
The American Journal of Surgical Pathology|October 23, 2013
Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a): an interobserver study among genitourinary pathologistsVijayalakshmi Ananthanarayanan, Yi Pan, Maria Tretiakova, et al.
The American Journal of Surgical Pathology|July 28, 2022
Clinicopathologic Spectrum of Secondary Solid Tumors of the Prostate of Nonurothelial Origin: Multi-institutional Evaluation of 85 CasesAndres M Acosta, Jennifer B Gordetsky, Katrina Collins, et al.
Archives of Pathology & Laboratory Medicine|August 6, 2014
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer FoundationMahul B Amin, Daniel W Lin, John L Gore, et al.
The American Journal of Pathology|September 6, 2011
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypesChristopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, et al.
The American Journal of Pathology|February 13, 2002
Evaluation of non-formalin tissue fixation for molecular profiling studiesJohn W Gillespie, Carolyn J M Best, Verena E Bichsel, et al.
The American Journal of Surgical Pathology|October 5, 2018
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the KidneyLisha Wang, Yuping Zhang, Ying-Bei Chen, et al.
The Journal of Pathology|October 18, 2023
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancerRadhika A Patel, Erolcan Sayar, Ilsa Coleman, et al.
Pageof 64